SMA
ELV icon

Seven Mile Advisory’s Elevance Health ELV Stock Holding History

Seven Mile Advisory’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-660
Closed -$287K – 182
2025
Q1 		$287K Buy
+660
New +$265K 0.19% 118
2024
Q4 		– Sell
-670
Closed -$348K – 175
2024
Q3 		$348K Buy
670
+30
+5% +$16K 0.23% 89
2024
Q2 		$347K Buy
640
+93
+17% +$49.2K 0.26% 78
2024
Q1 		$284K Buy
547
+19
+4% +$9.45K 0.22% 104
2023
Q4 		$249K Buy
+528
New +$244K 0.22% 107

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Seven Mile Advisory's ELV Position: Q2 2025 in Review

Seven Mile Advisory sold out of Elevance Health (ELV) in Q2 2025, closing a stake of 660 shares — an estimated $287K sold.

Seven Mile Advisory first reported a position in ELV in Q4 2023 and held it in 5 quarters. The position peaked at $348K in Q3 2024. 1,590 funds tracked by Wall St. Rank hold ELV as of Q2 2025.

  • Seven Mile Advisory reported no remaining Elevance Health position as of Q2 2025 after selling out during the quarter.
  • Seven Mile Advisory sold 660 Elevance Health shares in Q2 2025, an estimated $287K.
  • Seven Mile Advisory first reported a position in Elevance Health in Q4 2023 and held it in 5 quarters.
  • Seven Mile Advisory's Elevance Health position peaked at $348K in Q3 2024.
  • 1,590 funds tracked by Wall St. Rank held Elevance Health as of Q2 2025.

Based on Seven Mile Advisory's 13F filing for Q2 2025, filed 14 Aug 2025.